Samil Pharmaceutical Co.,Ltd (KRX:000520)
11,290
+200 (1.80%)
At close: Feb 20, 2026
KRX:000520 Market Cap
KRX:000520 has a market cap or net worth of 239.68 billion as of February 20, 2026. Its market cap has decreased by -16.68% in one year.
Market Cap
239.68B
Enterprise Value
397.64B
Revenue
215.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,290.00
Market Cap Chart
Since August 30, 1995, KRX:000520's market cap has increased from 13.98B to 239.68B, an increase of 1,614.76%. That is a compound annual growth rate of 9.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 235.44B | 14.45% |
| Dec 30, 2025 | 205.72B | -26.31% |
| Dec 30, 2024 | 279.17B | 188.10% |
| Dec 28, 2023 | 96.90B | -11.01% |
| Dec 29, 2022 | 108.89B | 2.33% |
| Dec 30, 2021 | 106.42B | -17.45% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suheung | 261.30B |
| Daewon Pharmaceutical | 254.20B |
| Chong Kun Dang Holdings | 253.26B |
| Samjin Pharmaceuticals | 240.37B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| HLB Pharmaceutical | 229.45B |
| AptaBio Therapeutics | 224.47B |
| REYON Pharmaceutical | 218.81B |